News About: Pharm. Industry


Celltrion Group Chairman Jung-Jin Seo starts to manage overseas businesses

Celltrion Group Chairman Jung-Jin Seo are visiting partnering companies in about 40 countries, and is discussing detailed business strategies about its products with CEOs and directors. According to Celltrion Group, ...

Patent Court gives decision in favor of Layla generics, nullifying its composition patent

The composition patent of ‘Layla(PMG Pharm),’ a natural drug for osteoarthritis making approximately KRW 20 billion sales, received a decision of nullification at the Patent Court. Mother’s Pharm led the nullificatio...

Huons Jecheon Factory being selected for ‘Demo Project for Smart Factories’ for first time as pharma

Huons, a subsidiary of Huons Global(CEO Sung-Tae Yoon & Wan-Sup Kim), announced they were selected for the ‘Demo Project for Establishment of Smart Factories’ for the first time as a pharmaceutical company. Located i...

Green Cross Cell’s Immune Cell-LC designated as orphan drug for brain tumor from FDA

Green Cross Cell(Duk-Joo Lee), a cell therapy company, announced on the 17th that their ‘Immune Cell-LC’ was designated as orphan drug from the U.S. FDA on the 17th. Immune Cell-LC acquired approval as an anticancer ...

One of 5 listed pharmas spending more than 10% of their sales into R&D

Listed pharmaceutical companies have been criticized to pay no attention in making investment into R&D. Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceutical companies’ 2018 first half busines...

Daewoong’s Nabota enters advanced market with Canadian approval

Daewoong Pharmaceutical’s Nabota has finally opened a new pharmaceutically advanced market. Daewoong Pharmaceutical(CEO Seung-Ho Jeon) announced its self-developed botulinum toxin product ‘Nabota’ was approved from t...

Unimed Pharm passes U.S. FDA’s onsite inspection for disposable artificial tears

A eye drop company Unimed Pharm(CEO Gun-Nam Kim) announced on the 20th that they successfully passed the U.S. FDA onsite inspection recently for the disposable eye drop ‘Carboxymethylcellulose sodium 0.5%.’ The compa...

GC Pharm starts to ship flue vaccines for this season in Korea

Influenza(flu) vaccines have started to be shipped. GC Pharm(CEO Eun-Cheol Huh) announced on the 20th that they have started to ship the 2018-2019 seasonal trivalent and tetravalent vaccines ‘GCFlu Prefilled Syringe ...

Kolon Pharma signs KRW 14 billion co-promotion with Abbott Korea

Kolon Pharma(CEO Woo-Seok Lee) announced on the 20th that they signed a co-promotion agreement for 5 products including Klaricid Film Coated Film with Abbott Laboratories. The agreed products are Klaricid Film Coated...

Listed pahrmas weakened in profitability

It was criticized listed pharmaceutical companies have been weakened in profitability. Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceutical companies’ 2018 2nd quarter business performance, a...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.